Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lilly claims mGluR antagonists for neurodegeneration

April 26, 1996

OPC-14523 improves learning in preclinical models

April 26, 1996

Mediolanum synthesizes AChE inhibitors for Alzheimer's

April 26, 1996

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

Avonex approval imminent

April 26, 1996

New antidepressants disclosed by Yamanouchi

April 26, 1996

Mitsui Seiyaku describes sigma-opioid antagonist

April 26, 1996

Sigma-opioid ligands from ADIR

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

IRI-695 for anxiety and depression

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...